Update: Progyny, Inc. Announces Participation in Upcoming Investor Conferences

New York, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced its participation in two upcoming investor conferences.

David Schlanger, Progyny’s Chief Executive Officer, will participate in a fireside chat at Piper Jaffray’s 31st Annual Healthcare Conference on Thursday, December 5th at 12:30 PM EST.  A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com.

Mr. Schlanger and Pete Anevski, Progyny’s President, CFO and COO, will be available for one-on-one meetings with attending investors.

Mr. Schlanger and Mr. Anevski are also participating in the Citi 2019 Global Healthcare Conference on Wednesday, December 11th and will be available for one-on-one meetings with attending investors.

Attending investors are encouraged to contact the respective conference coordinators to schedule a meeting.

About ProgynyProgyny is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.  Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been named a CNBC 50 Disruptor for three years in a row, to the INC. 5000, Crain’s Fast 50 for NYC, and Modern Healthcare’s Best Places to Work in Healthcare for two years in a row. For more information, visit www.progyny.com.

For Further Information, Please Contact:
Investors:
James Hart
[email protected]

Media:
Selena Yang
[email protected]

You May Also Be Interested In

• SOS Ltd. Announces Receipt of NYSE Non-compliance Letter Regarding Class A Ordinary Shares Trading Price
• Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Premium Income Corporation Announces Monthly Distribution